Importantly, we have shown that the serine/threonine phosphatase activity of EYA4 is important for breast cancer progression and metastasis, suggesting that targeting the EYA4 phosphatase activity could help devise new cancer treatments directed against primary tumors and distant metastasis. The gene discussed is EYA4; the disease is breast cancer.